ANI Pharmaceuticals | 流动负债



金融业
股票价格
USD
资产
USD 1.41B
现金及等价物
USD 262.61M
销售成本
USD 116.02M
流动资产
USD 698.4M
流动负债
USD 270.56M
债务
USD 620.31M
EBIT
USD 22.83M
EBITDA
USD 59.6M
员工
642
EPS每股收益
USD 2.04
股本和储备
USD 505.82M
销售毛利
USD 111.79M
债务利息支出
USD 4.73M
贷款资金
USD 297.68M
市值
USD 1.63B
净收入
USD 26.27M
营业费用
USD 505.82M
营业利润
USD 22.83M
普通股股本
USD 21.73M
PE价格收益
USD 98.67
税前利润
USD 49.52M
销售收入
USD 227.81M
销售和管理费用
USD 76.66M
股票
USD 146.48M
贸易债权人
USD 69.8M
应收帐款人
USD 252.62M


流动负债 更改 日
AbbVie USD 43.29B 3.9B 2025-12
ANI Pharmaceuticals USD 270.56M 33.72M 2025-09
Assertio Holdings USD 166.78M 34.25M 2025-09
Aurora Cannabis CAD 124.12M 32.76M 2025-09
Canopy Growth CAD 81.1M 17.56M 2025-09
Eli Lilly USD 35.23B 4.91B 2025-12
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Heron Therapeutics USD 89.71M 168.89M 2025-09
Hikma Pharmaceutical USD 2.06B 78M 2025-06
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Novartis USD 32B 286M 2025-09
Omeros USD 85.5M 2.28M 2025-06
Perrigo USD 1.15B 19.2M 2025-09
Sun Pharmaceuticals INR 234.15B 52.21B 2025-09
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12


ANI Pharmaceuticals 流动负债 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.